Effect of High Intensity Focused Electromagnetic Field on Postnatal Diastasis Recti

NCT07442487 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-03-02

No results posted yet for this study

Summary

This study will be conducted to investigate the effect of high-intensity focused electromagnetic field on postnatal diastasis recti.

Conditions

  • Diastasis Recti

Interventions

OTHER

A program of abdominal exercises

All women in both groups will be adhered to a program of abdominal strengthening exercise that includes static abdominal, abdominal crunch, and external oblique exercises. Each exercise will be repeated 15 times and will be increased by five repetitions each week throughout the study period, with total time of 20 minutes/ session, 3 times weekly for 8 weeks.

DEVICE

High-intensity focused electromagnetic field

High-intensity focused electromagnetic field will be administered only to the experimental group, targeting the abdominal region for 30 minutes per session, twice weekly for 8 weeks. Sessions will be performed in the supine position, with the applicator centered over the umbilicus and secured to prevent movement. Stimulation intensity will start at 0% and be gradually increased to achieve strong yet tolerable muscle contractions, guided by continuous visual monitoring and patient feedback to ensure comfort and uniform abdominal activation.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Soheir Mahmoud El-Kosery, PhD · Professor, Cairo University

  • Manal Ahmed El-Shafei Mohamed, PhD · Ass. Professor, Cairo University

  • Mohammed Fathi Abo Hashim, PhD · Assis. Professor, Zagazig University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-05-01
Completion
2026-05-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07442487 on ClinicalTrials.gov